SWI/SNF Mutations Confer Resistance to Ibrutinib Plus Venetoclax in MCL

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2018-210
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Early-Stage Induction of SWI/SNF Mutations During Esophageal Squamous Cell Carcinogenesis

PLoS ONE
Multidisciplinary
2016English

SWI/SNF in Cardiac Progenitor Cell Differentiation

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2013English

MEK1 Mutations Confer Resistance to MEK and B-Raf Inhibition

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

The Many Faces of Plant SWI/SNF Complex

Molecular Plant
Plant ScienceMolecular Biology
2014English

SWI/SNF Proteins as Targets in Cancer Therapy

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2014English

FLT3 D835 Mutations Confer Differential Resistance to Type II FLT3 Inhibitors

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Spontaneous Mutations That Confer Antibiotic Resistance in Helicobacter Pylori

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Author Correction: Mutations in the SWI/SNF Complex Induce a Targetable Dependence on Oxidative Phosphorylation in Lung Cancer

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

The SWI/SNF Complex Binds to and Inhibits YAP/TAZ

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy